Twenty-five percent positive biopsy rate in a high risk prostate cancer screening program with a PSA ≤ 2.5 ng/ml

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 4557-4557 ◽  
Author(s):  
A. A. Konski ◽  
S. Feigenberg ◽  
S. Raysor ◽  
D. Eisenberg ◽  
I. Mirchandani ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Screening ◽  
High Risk ◽  
Screening Program ◽  
Prostate Cancer Screening ◽  
High Risk Prostate Cancer ◽  
Positive Biopsy ◽  
Cancer Screening Program ◽  
Risk Prostate Cancer ◽  
Biopsy Rate

Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer

2020 ◽  
Vol 38 (9) ◽  
pp. 735.e9-735.e15
Author(s):  
David D. Yang ◽  
Vinayak Muralidhar ◽  
Brandon A. Mahal ◽  
Marie E. Vastola ◽  
Ninjin Boldbaatar ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
High Risk Prostate Cancer ◽  
Positive Biopsy ◽  
Specific Mortality ◽  
Risk Prostate Cancer ◽  
Cancer Specific Mortality

scholarly journals PMW3: ECONOMICAL ANALYSIS OF THE RESULTS OF PROSTATE CANCER SCREENING PROGRAM

1999 ◽  
Vol 2 (5) ◽  
pp. 400
Author(s):  
LE Komarova ◽  
BP Matveev ◽  
BV Buharkin ◽  
S Kobina
Keyword(s):  
Prostate Cancer ◽  
Cancer Screening ◽  
Screening Program ◽  
Prostate Cancer Screening ◽  
Economical Analysis ◽  
Cancer Screening Program

scholarly journals Community-Based Free Prostate Cancer Screening Program

2007 ◽  
Vol 1 (3) ◽  
pp. 215-220 ◽  
Author(s):  
Lina. Jandorf ◽  
Matthew S. Chang ◽  
Kayode. Smith ◽  
Alexis. Florio ◽  
Simon J. Hall
Keyword(s):  
Prostate Cancer ◽  
Cancer Screening ◽  
Screening Program ◽  
Prostate Cancer Screening ◽  
Community Based ◽  
Cancer Screening Program

The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen

2004 ◽  
Vol 42 (9) ◽  
Author(s):  
Wolfgang Herrmann ◽  
Michael Stöckle ◽  
Marga Sand-Hill ◽  
Ulrich Hübner ◽  
Markus Herrmann ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Prostate Specific Antigen ◽  
Screening Program ◽  
Prostate Cancer Screening ◽  
Specific Antigen ◽  
First Line ◽  
Line Parameter ◽  
Cancer Screening Program ◽  
Total Psa

AbstractThe aim of this study was to compare the diagnostic utility of complexed prostate-specific antigen (cPSA) with total PSA (tPSA) in screening for prostate cancer. Serum concentrations of tPSA and cPSA were measured in 4479 adult men during the prostate cancer screening program in the Saarland region (Germany). The percentage of men with c/tPSA ratio above the cut-off value of 0.75 increased with increasing tPSA intervals: tPSA 0–0.9 µg/l, 4.4%; 1.0–1.9 µg/l, 24.3%; 2.0–2.9 µg/l, 43.9%; 3.0–3.9 µg/l, 50.4%; and 4.0–20 µg/l, 60.2%. The commonly accepted tPSA cut-off value of 3.9 µg/l matched to the 93rd percentile of the overall population (corresponding cPSA value, 2.9 µg/l). A total of 202 men out of 313 with increased cPSA had increased c/tPSA ratio (cut-off ≥ 0.75) vs. 186 out of 312 men with increased tPSA. Thus, an additional 16 men at high risk for prostate cancer were selected only if cPSA was utilised as a first line parameter. Our data show that, compared to tPSA, cPSA measurement will always detect more high-risk patients, independent of the cut-off levels utilised for cPSA, tPSA and c/tPSA ratio. cPSA is more effective than tPSA in selecting subjects with an elevated c/tPSA ratio who are at high risk of prostate cancer. Thus, cPSA might be seen as the superior first-line parameter in screening for prostate cancer. Using lower cut-off values for tPSA or cPSA than the commonly accepted values seems reasonable for screening purposes.

PD40-05 DETERMINANTS OF DEFAULT FROM FOLLOW-UP CARE IN A PROSTATE CANCER SCREENING PROGRAM

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Mark Ferretti ◽  
Michael Goltzman ◽  
Akhil Saji ◽  
Neel Patel ◽  
Denton Allman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Screening ◽  
Screening Program ◽  
Prostate Cancer Screening ◽  
Cancer Screening Program ◽  
Follow Up Care
Sign in / Sign up

Export Citation Format

Share Document